Isolation and characterization of glioblastoma-associated homozygously deleted DNA fragments from chromosomal region 9p21 suggests involvement of multiple tumour suppressor genes

Journal of Pathology

Volumn 189, Issue 3, 1999, Pages 402-409

  Simons, Annet ^a   Jeuken, Judith W M ^b   Eleveld, Marc J ^b   Boerman, Rudolf H ^b   Geurts Van Kessel, Ad ^b  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^b NONE

Author keywords

9p21; Glioblastoma; Homozygous deletion; p16; Representational difference analysis (RDA); Tumour suppressor gene (TSG)

Indexed keywords

DNA FRAGMENT;

ANIMAL CELL; ARTICLE; CHROMOSOME 9P; DNA DETERMINATION; GENE DELETION; GLIOBLASTOMA; HUMAN; HUMAN CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RODENT; TUMOR SUPPRESSOR GENE; XENOGRAFT;

ANIMALS; CHROMOSOMES, HUMAN, PAIR 9; DNA, NEOPLASM; GENE DELETION; GENES, TUMOR SUPPRESSOR; GENETIC MARKERS; GLIOBLASTOMA; HOMOZYGOTE; HUMANS; NEOPLASM TRANSPLANTATION; POLYMERASE CHAIN REACTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 0032881474     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199911)189:3<402::AID-PATH437>3.0.CO;2-8     Document Type: Article

References (29)

1. Lisitsyn N, Lisitsyn N, Wigler M. Cloning the difference between two complex genomes. Science 1993; 259: 946-951.
2. Lisitsyn NA, Lisitsina NM, Dalbagni G, et al. Comparative genomic analysis of tumors: Detection of DNA losses and amplification. Proc Natl Acad Sci USA 1995; 92: 151-155.
3. Schutte M, da Costa LT, Hahn SA, et al. Identification by representational difference analysis of a homozygous deletion in pancreatic carcinoma that lies within the BRCA2 region. Proc Natl Acad Sci USA 1995; 92: 5950-5954.
4. Simons A, Janssen IM, Suijkerbuijk RF, et al. Isolation of osteosarcoma-associated amplified DNA sequences using representational difference analysis. Genes Chromosomes Cancer 1997; 20: 196-200.
5. Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997; 275: 1943-1947.
6. Kleihues P, Burger PC, Scheithauer BW. World Health Organization International Histological Classification of Tumors: Histological Typing of Tumours of the Central Nervous System. Berlin: Springer-Verlag, 1993.
7. Louis DN, Gusella JF. A tiger behind many doors: multiple genetic pathways to malignant glioma. TIG 1995; 11: 412-415.
8. von Deimling A, Louis DN, Wiestler OT. Molecular pathways in the formation of gliomas. Glia 1995; 15: 328-338.
9. van de Kelft E. Molecular pathogenesis of astrocytoma and glioblastoma multiforme. Acta Neurochir Wien 1997; 139: 589-599.
10. Kon H, Sonoda Y, Kumabe T, Yoshimoto T, Sekiya T, Murakami Y. Structural and functional evidence for the presence of tumor suppressor genes on the short arm of chromosome 10 in human gliomas. Oncogene 1998; 16: 257-263.
11. Reifenberger J, Reifenberger G, Liu L, James CD, Wechsler W, Collins VP. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am J Pathol 1994; 145: 1175-1190.
12. Maier D, Comparone D, Taylor E, et al. New deletion in low-grade oligodendroglioma at the glioblastoma suppressor locus on chromosome 10q25-26. Oncogene 1997; 15: 997-1000.
13. Kamb A, Gruis NA, Weaver-Feldhaus J, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994; 264: 436-440.
14. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16: 1215.
15. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning, A Laboratory Manual. 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
16. Weterman MAJ, Wilbrink M, Geurts van Kessel A. Fusion of the transcription factor TFE3 gene to a novel gene, PRCC, in t(X;1)(p11;q21)-positive papillary renal cell carcinomas. Proc Natl Acad Sci USA 1996; 93: 15294-15298.
17. Suijkerbuijk RF, Sinke RJ, Olde Weghuis DEM, et al. Amplification of chromosome 12p11.2-p12.1 in a metastasis of an i(12p)-negative seminoma: relationship to tumor progression? Cancer Genet Cytogenet 1994; 78: 145-152.
18. Bodmer D, Eleveld MJ, Ligtenberg MJL, et al. An alternative route for multistep tumorigenesis in a novel case of hereditary renal cell cancer and a t(2;3)(q35;q21) chromosome translocation. Am J Hum Genet 1998; 62: 1475-1483.
19. Dib C, Faure S, Fizames C, et al. A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature 1996; 380: 152-154.
20. Moulton T, Samara G, Chung WY, et al. MTS/p16/CDKN2 lesions in primary glioblastoma multiforme. Am J Pathol 1995; 146: 613-619.
21. Kyritsis AP, Zhang B, Zhang W, et al. Mutations of the p16 gene in gliomas. Oncogene 1996; 12: 63-67.
22. Barker FG, Chen P, Furman F, Aldape KD, Edwards MS, Israel MA. P16 deletion and mutation analysis in human brain tumors. J Neurooncol 1997; 31: 17-23.
23. INK4a/CDKN2A in human glioma. Oncogene 1997; 14: 603-609.
24. Hamada K, Kohno T, Kawanishi M, Ohwada S, Yokota J. Association of CDKN2A (p16)/CDKN2B (p15) alterations and homozygous chromosome arm 9p deletions in human lung carcinoma. Genes Chromosomes Cancer 1998; 22: 232-240.
25. An HX, Niederacher D, Picard F, van Roeyen C, Bender HG, Beckmann MW. Frequent allele loss on 9p21-22 defines a smallest common region in the vicinity of the CDKN2 gene in sporadic breast cancer. Genes Chromosomes Cancer 1996; 17: 14-20.
26. Cairns P, Okami K, King P, et al Genomic organization and mutation analysis of Hel-Nl in lung cancers with chromosome 9p21 deletions. Cancer Res 1997; 57: 5356-5359.
27. Wiest JS, Franklin WA, Otstot JT, et al. Identification of a novel region of homozygous deletion on chromosome 9p in squamous cell carcinoma of the lung: the location of a putative tumor suppressor gene. Cancer Res 1997; 57: 1-6.
28. Farrell WE, Simpson DJ, Bicknell JE, Talbot AJ, Bates AS, Clayton RN. Chromosome 9p deletions in invasive and non-invasive nonfunctional pituitary adenomas: the deleted region involves markers outside of the MTS1 and MTS2 genes. Cancer Res 1997; 57: 2703-2709.
29. Wagner SN, Wagner C, Briedigkeit L, Goos M. Homozygous deletion of the p16INK4a and the p15INK4b tumour suppressor genes in a subset of human sporadic cutaneous malignant melanoma. Br J Dermatol 1998; 138: 13-21.